COGNITION THERAPEUTICS INC. - COMMON STOCK
0.4350
04-October-24 15:59:44
15 minutes delayed
Stocks
9.9999999999989E-05
+0.02%
Today's range
0.4300 - 0.4489
ISIN
N/A
Source
NASDAQ
-
Cognition Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
11 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
CORRECTION -- Cognition Therapeutics to Report First Quarter 2022 Financial Results on May 11, 2022
04 May 2022 17:54:44 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Report First Quarter 2022 Financial Results on May 11, 2022
04 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
03 May 2022 08:00:03 By Nasdaq GlobeNewswire
-
25 Apr 2022 16:01:00 By Nasdaq GlobeNewswire
-
25 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference
06 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Year End 2021 Financial Results and Provides Business Update
30 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Report Fourth Quarter and Full Year 2021 Results
22 Mar 2022 08:00:03 By Nasdaq GlobeNewswire
-
10 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Participation in March Investment Conferences
08 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
08 Feb 2022 07:30:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Provides Update on Corporate and Pipeline Progress and Reviews Goals for 2022
10 Jan 2022 07:30:01 By Nasdaq GlobeNewswire
-
04 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
21 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
30 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
-
15 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
-
03 Nov 2021 08:00:03 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Pricing of Upsized Initial Public Offering
08 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Launch of its Initial Public Offering
04 Oct 2021 07:54:24 By Nasdaq GlobeNewswire